|
|
Volumn 32, Issue 9, 2008, Pages 865-867
|
|
Urologist's role in the treatment with new targeted therapies in advanced renal cell carcinoma;El urólogo y las nuevas dianas terapéuticas en el cáncer renal avanzado.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MAMMALIAN TARGET OF RAPAMYCIN;
MONOCLONAL ANTIBODY;
PROTEIN KINASE;
PROTEIN TYROSINE KINASE;
ADJUVANT CHEMOTHERAPY;
CANCER STAGING;
DRUG ANTAGONISM;
EDITORIAL;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
PATHOLOGY;
PHYSICIAN ATTITUDE;
UROLOGY;
ANTIBODIES, MONOCLONAL;
CARCINOMA, RENAL CELL;
CHEMOTHERAPY, ADJUVANT;
HUMANS;
KIDNEY NEOPLASMS;
NEOPLASM STAGING;
PHYSICIAN'S ROLE;
PROTEIN KINASES;
PROTEIN-TYROSINE KINASES;
UROLOGY;
MLCS;
MLOWN;
|
|
EID: 58149397466
PISSN: 02104806
EISSN: None
Source Type: Journal
DOI: 10.1016/s0210-4806(08)73952-4 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
